Blocking GSDMD-mediated pyroptosis partially rescues the growth defects of Mll4−/− melanoma cells and markedly increases the tumor burden in immune-competent mice treated with or without PD-1 blockade antibody (Fig. 7l, m). The gene discussed is KMT2D; the disease is melanoma.